The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A retrospective analysis of the effect of continuing bevacizumab beyond disease progression in patients with non-small cell lung cancer.
Takashi Yokoi
No relevant relationships to disclose
Takayasu Kurata
No relevant relationships to disclose
Yoshitaro Torii
No relevant relationships to disclose
Yuichi Katashiba
No relevant relationships to disclose
Maiko Niki
No relevant relationships to disclose
Yusuke Sawai
No relevant relationships to disclose
Yuta Yamanaka
No relevant relationships to disclose
Naoko Murakami Satsutani
No relevant relationships to disclose
Shosaku Nomura
No relevant relationships to disclose